Elanco reaches for growth in billion-dollar itchy dog market
The Indianapolis-based company received U.S. regulatory approval last week for its second medicine in 18 months in what it describes as the $1.3 billion dog dermatology market.
Elanco
-
Q&A with Elanco’s Jeff Simmons on blockbusters, challenges and growing up on a vineyard
Elanco opened the doors of its new headquarters at the former GM stamping plant site this week.
Read More -
Water-themed sculpture brings art to new Elanco campus
“Water in Dripping, River” is a stainless steel artwork in Zheng Lu’s signature format that depicts splashes of water captured in midair.
Read More -
Pet perks: More employers offering pet insurance, letting pups come to the office
The rise of pet insurance and pet-friendly workplaces comes amid wider societal changes with health benefits experts citing people waiting longer to have children and increasingly treating pets as part of the family.
Read More -
Sculpture at Elanco campus expected to make a splash for public art
“Water in Dripping, River,” a stainless steel sculpture by Chinese artist Zheng Lu, is an $846,000 project that will set a new standard for works financed through the Public Art for Neighborhoods ordinance.
Read More
Articles
Elanco announces plans to bolster Indy-based R&D, cut 300 jobs worldwide
An Elanco spokeswoman said cuts to the company’s Indiana workforce are “very minimal.” Most of the eliminated positions are from the company’s planned closure of its German R&D facility.
Lilly CEO calls on state to boost power supply as company seeks to build supercomputer
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
New Indianapolis venture studio aims to launch 8-12 startups in next few years
Indianapolis-based Alloy Partners says its OneHealth Studio, a venture studio that quietly began operating last month in partnership with Elanco Animal Health Inc., will be ready to create its first startups early next year.
Elanco’s Q3 earnings top Wall Street forecasts as company continues to deal with debt
Despite reporting a loss, the company saw quarterly growth in the double digits and raised its full-year earnings estimate.
Abrupt crane bay demolition at former GM stamping plant site caught many off guard
It took only a five-line clause in the state’s August land sale to Elanco Animal Health to bring down what was left of a nearly 100-year-old crane bay along the western bank of the White River.
Pharmaceutical, life science industries drive trade surge between Indiana and Portugal
Indiana’s growing partnership with Portugal includes imports like rubber, plastics and chemicals, the latter of which is driven largely by pharmaceuticals, according to a Portuguese trade representative.
Former Elanco campus in Greenfield seen as catalyst for future ag district
As Elanco Animal Health Inc. settles into its new home in Indianapolis, leaders in Greenfield have turned their attention to the future of the company’s former corporate campus.
White River State Park returns $30M crane bay grant to Lilly Endowment
A demolition ended plans to turn the crane bay structure into an events pavilion that could host farmers markets, weddings, corporate gatherings and other activities.
Elanco opens ‘doors to the future’ with new $200M-plus Indianapolis headquarters
At Wednesday’s ribbon cutting, Elanco CEO Jeff Simmons said the new, three-building campus and developing OneHealth Innovation District “will write the history for the next 70 years of Elanco.”
IEDC approves $10M in federal funding to launch Indianapolis venture studio
The Indiana Economic Development Corp. approved $10 million in federal funding for the planned OneHealth Venture Studio, which will operate on Elanco Animal Health’s new Indianapolis campus.
Elanco reports pet parasite treatment quickly hit $100M blockbuster status
The sales momentum comes as Elanco prepares to open its $200 million-plus corporate campus next month on the west side of downtown Indianapolis.
Crane bay structure at former GM stamping plant site under demolition, plans for event pavilion scrapped
Retention of the crane bay structure had long been considered an integral part of the stamping plant redevelopment by neighbors and city leaders.
State’s exit from GM site ownership signals new economic development approach
“The governor has been very clear: We’re just not in the land development business, and it’s not a core competency,” Commerce Secretary David Adams told IBJ.
State sells former GM stamping plant site to Elanco for $27M
Indiana Gov. Mike Braun said the agreement “enables Elanco and its partners, including Purdue University, to accelerate the creation of an innovation district in downtown Indianapolis.”
Elanco CEO says new products helping to turn the corner on growth
Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co.
Elanco spearheads Nutrition Secure Indianapolis initiative to provide food aid to west-side families
As the Greenfield-based animal health company prepares to move into its new neighborhood, it’s working with community partners to help ensure some of its new neighbors have adequate food access.
UPDATE: Elanco shares jump 16% as company raises full-year guidance
The company, which makes vaccines, antibiotics and other animal-health products, said it now expects full-year revenue of between $4.57 billion and $4.62 billion.
Elanco ramps up debt repayment, sells future royalties of flea and tick medicine for human use
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
Elanco buys manufacturing facility in England for $25M
Greenfield-based Elanco said the facility has played a vital role in producing a number of product lines for the firm, representing $160 million to $180 million in annual farm animal revenue.